Plasmodium	B:C0032150
falciparum	I:C0032150
Choline	O
Kinase	I:C0008415
Inhibition	O
Leads	O
to	O
a	O
Major	O
Decrease	O
in	O
Phosphatidylethanolamine	O
Causing	O
Parasite	O
Death	O
Malaria	O
is	O
a	O
life	O
-	I:C2826244
threatening	I:C2826244
disease	O
caused	O
by	O
different	O
species	O
of	O
the	O
protozoan	O
parasite	I:C0585171
Plasmodium	O
,	O
with	O
P.	O
falciparum	I:C0032150
being	O
the	O
deadliest	O
.	O

Plasmodium	O
falciparum	I:C0032150
Choline	B:C0008415
Kinase	I:C0008415
Inhibition	O
Leads	O
to	O
a	O
Major	O
Decrease	O
in	O
Phosphatidylethanolamine	O
Causing	O
Parasite	O
Death	O
Malaria	O
is	O
a	O
life	O
-	I:C2826244
threatening	I:C2826244
disease	O
caused	O
by	O
different	O
species	O
of	O
the	O
protozoan	O
parasite	I:C0585171
Plasmodium	O
,	O
with	O
P.	O
falciparum	I:C0032150
being	O
the	O
deadliest	O
.	O

Plasmodium	O
falciparum	I:C0032150
Choline	O
Kinase	I:C0008415
Inhibition	O
Leads	O
to	O
a	O
Major	O
Decrease	O
in	O
Phosphatidylethanolamine	B:C1450468
Causing	O
Parasite	O
Death	O
Malaria	O
is	O
a	O
life	O
-	I:C2826244
threatening	I:C2826244
disease	O
caused	O
by	O
different	O
species	O
of	O
the	O
protozoan	O
parasite	I:C0585171
Plasmodium	O
,	O
with	O
P.	O
falciparum	I:C0032150
being	O
the	O
deadliest	O
.	O

Plasmodium	O
falciparum	I:C0032150
Choline	O
Kinase	I:C0008415
Inhibition	O
Leads	O
to	O
a	O
Major	O
Decrease	O
in	O
Phosphatidylethanolamine	O
Causing	O
Parasite	B:C0030498
Death	O
Malaria	O
is	O
a	O
life	O
-	I:C2826244
threatening	I:C2826244
disease	O
caused	O
by	O
different	O
species	O
of	O
the	O
protozoan	O
parasite	I:C0585171
Plasmodium	O
,	O
with	O
P.	O
falciparum	I:C0032150
being	O
the	O
deadliest	O
.	O

Plasmodium	O
falciparum	I:C0032150
Choline	O
Kinase	I:C0008415
Inhibition	O
Leads	O
to	O
a	O
Major	O
Decrease	O
in	O
Phosphatidylethanolamine	O
Causing	O
Parasite	O
Death	B:C0011065
Malaria	O
is	O
a	O
life	O
-	I:C2826244
threatening	I:C2826244
disease	O
caused	O
by	O
different	O
species	O
of	O
the	O
protozoan	O
parasite	I:C0585171
Plasmodium	O
,	O
with	O
P.	O
falciparum	I:C0032150
being	O
the	O
deadliest	O
.	O

Plasmodium	O
falciparum	I:C0032150
Choline	O
Kinase	I:C0008415
Inhibition	O
Leads	O
to	O
a	O
Major	O
Decrease	O
in	O
Phosphatidylethanolamine	O
Causing	O
Parasite	O
Death	O
Malaria	B:C0024530
is	O
a	O
life	O
-	I:C2826244
threatening	I:C2826244
disease	O
caused	O
by	O
different	O
species	O
of	O
the	O
protozoan	O
parasite	I:C0585171
Plasmodium	O
,	O
with	O
P.	O
falciparum	I:C0032150
being	O
the	O
deadliest	O
.	O

Plasmodium	O
falciparum	I:C0032150
Choline	O
Kinase	I:C0008415
Inhibition	O
Leads	O
to	O
a	O
Major	O
Decrease	O
in	O
Phosphatidylethanolamine	O
Causing	O
Parasite	O
Death	O
Malaria	O
is	O
a	O
life	B:C2826244
-	I:C2826244
threatening	I:C2826244
disease	O
caused	O
by	O
different	O
species	O
of	O
the	O
protozoan	O
parasite	I:C0585171
Plasmodium	O
,	O
with	O
P.	O
falciparum	I:C0032150
being	O
the	O
deadliest	O
.	O

Plasmodium	O
falciparum	I:C0032150
Choline	O
Kinase	I:C0008415
Inhibition	O
Leads	O
to	O
a	O
Major	O
Decrease	O
in	O
Phosphatidylethanolamine	O
Causing	O
Parasite	O
Death	O
Malaria	O
is	O
a	O
life	O
-	I:C2826244
threatening	I:C2826244
disease	B:C0012634
caused	O
by	O
different	O
species	O
of	O
the	O
protozoan	O
parasite	I:C0585171
Plasmodium	O
,	O
with	O
P.	O
falciparum	I:C0032150
being	O
the	O
deadliest	O
.	O

Plasmodium	O
falciparum	I:C0032150
Choline	O
Kinase	I:C0008415
Inhibition	O
Leads	O
to	O
a	O
Major	O
Decrease	O
in	O
Phosphatidylethanolamine	O
Causing	O
Parasite	O
Death	O
Malaria	O
is	O
a	O
life	O
-	I:C2826244
threatening	I:C2826244
disease	O
caused	O
by	O
different	O
species	B:C1705920
of	O
the	O
protozoan	O
parasite	I:C0585171
Plasmodium	O
,	O
with	O
P.	O
falciparum	I:C0032150
being	O
the	O
deadliest	O
.	O

Plasmodium	O
falciparum	I:C0032150
Choline	O
Kinase	I:C0008415
Inhibition	O
Leads	O
to	O
a	O
Major	O
Decrease	O
in	O
Phosphatidylethanolamine	O
Causing	O
Parasite	O
Death	O
Malaria	O
is	O
a	O
life	O
-	I:C2826244
threatening	I:C2826244
disease	O
caused	O
by	O
different	O
species	O
of	O
the	O
protozoan	B:C0585171
parasite	I:C0585171
Plasmodium	O
,	O
with	O
P.	O
falciparum	I:C0032150
being	O
the	O
deadliest	O
.	O

Plasmodium	O
falciparum	I:C0032150
Choline	O
Kinase	I:C0008415
Inhibition	O
Leads	O
to	O
a	O
Major	O
Decrease	O
in	O
Phosphatidylethanolamine	O
Causing	O
Parasite	O
Death	O
Malaria	O
is	O
a	O
life	O
-	I:C2826244
threatening	I:C2826244
disease	O
caused	O
by	O
different	O
species	O
of	O
the	O
protozoan	O
parasite	I:C0585171
Plasmodium	B:C0032148
,	O
with	O
P.	O
falciparum	I:C0032150
being	O
the	O
deadliest	O
.	O

Plasmodium	O
falciparum	I:C0032150
Choline	O
Kinase	I:C0008415
Inhibition	O
Leads	O
to	O
a	O
Major	O
Decrease	O
in	O
Phosphatidylethanolamine	O
Causing	O
Parasite	O
Death	O
Malaria	O
is	O
a	O
life	O
-	I:C2826244
threatening	I:C2826244
disease	O
caused	O
by	O
different	O
species	O
of	O
the	O
protozoan	O
parasite	I:C0585171
Plasmodium	O
,	O
with	O
P.	B:C0032150
falciparum	I:C0032150
being	O
the	O
deadliest	O
.	O

Increasing	O
parasitic	O
resistance	O
to	O
existing	O
antimalarials	B:C0003374
makes	O
the	O
necessity	O
of	O
novel	O
avenues	O
to	O
treat	O
this	O
disease	O
an	O
urgent	O
priority	O
.	O

Increasing	O
parasitic	O
resistance	O
to	O
existing	O
antimalarials	O
makes	O
the	O
necessity	O
of	O
novel	O
avenues	O
to	O
treat	B:C0087111
this	O
disease	O
an	O
urgent	O
priority	O
.	O

Increasing	O
parasitic	O
resistance	O
to	O
existing	O
antimalarials	O
makes	O
the	O
necessity	O
of	O
novel	O
avenues	O
to	O
treat	O
this	O
disease	B:C0012634
an	O
urgent	O
priority	O
.	O

The	O
enzymes	B:C0014442
responsible	O
for	O
the	O
synthesis	O
of	O
phosphatidylcholine	O
and	O
phosphatidylethanolamine	O
are	O
attractive	O
drug	O
targets	O
to	O
treat	O
malaria	O
as	O
their	O
selective	O
inhibition	O
leads	O
to	O
an	O
arrest	O
of	O
the	O
parasite	O
's	I:C0030498
growth	O
and	O
cures	O
malaria	O
in	O
a	O
mouse	O
model	I:C2986594
.	O

The	O
enzymes	O
responsible	O
for	O
the	O
synthesis	O
of	O
phosphatidylcholine	B:C1959616
and	O
phosphatidylethanolamine	O
are	O
attractive	O
drug	O
targets	O
to	O
treat	O
malaria	O
as	O
their	O
selective	O
inhibition	O
leads	O
to	O
an	O
arrest	O
of	O
the	O
parasite	O
's	I:C0030498
growth	O
and	O
cures	O
malaria	O
in	O
a	O
mouse	O
model	I:C2986594
.	O

The	O
enzymes	O
responsible	O
for	O
the	O
synthesis	O
of	O
phosphatidylcholine	O
and	O
phosphatidylethanolamine	B:C1450468
are	O
attractive	O
drug	O
targets	O
to	O
treat	O
malaria	O
as	O
their	O
selective	O
inhibition	O
leads	O
to	O
an	O
arrest	O
of	O
the	O
parasite	O
's	I:C0030498
growth	O
and	O
cures	O
malaria	O
in	O
a	O
mouse	O
model	I:C2986594
.	O

The	O
enzymes	O
responsible	O
for	O
the	O
synthesis	O
of	O
phosphatidylcholine	O
and	O
phosphatidylethanolamine	O
are	O
attractive	O
drug	O
targets	O
to	O
treat	B:C0087111
malaria	O
as	O
their	O
selective	O
inhibition	O
leads	O
to	O
an	O
arrest	O
of	O
the	O
parasite	O
's	I:C0030498
growth	O
and	O
cures	O
malaria	O
in	O
a	O
mouse	O
model	I:C2986594
.	O

The	O
enzymes	O
responsible	O
for	O
the	O
synthesis	O
of	O
phosphatidylcholine	O
and	O
phosphatidylethanolamine	O
are	O
attractive	O
drug	O
targets	O
to	O
treat	O
malaria	B:C0024530
as	O
their	O
selective	O
inhibition	O
leads	O
to	O
an	O
arrest	O
of	O
the	O
parasite	O
's	I:C0030498
growth	O
and	O
cures	O
malaria	O
in	O
a	O
mouse	O
model	I:C2986594
.	O

The	O
enzymes	O
responsible	O
for	O
the	O
synthesis	O
of	O
phosphatidylcholine	O
and	O
phosphatidylethanolamine	O
are	O
attractive	O
drug	O
targets	O
to	O
treat	O
malaria	O
as	O
their	O
selective	O
inhibition	O
leads	O
to	O
an	O
arrest	O
of	O
the	O
parasite	B:C0030498
's	I:C0030498
growth	O
and	O
cures	O
malaria	O
in	O
a	O
mouse	O
model	I:C2986594
.	O

The	O
enzymes	O
responsible	O
for	O
the	O
synthesis	O
of	O
phosphatidylcholine	O
and	O
phosphatidylethanolamine	O
are	O
attractive	O
drug	O
targets	O
to	O
treat	O
malaria	O
as	O
their	O
selective	O
inhibition	O
leads	O
to	O
an	O
arrest	O
of	O
the	O
parasite	O
's	I:C0030498
growth	B:C0018270
and	O
cures	O
malaria	O
in	O
a	O
mouse	O
model	I:C2986594
.	O

The	O
enzymes	O
responsible	O
for	O
the	O
synthesis	O
of	O
phosphatidylcholine	O
and	O
phosphatidylethanolamine	O
are	O
attractive	O
drug	O
targets	O
to	O
treat	O
malaria	O
as	O
their	O
selective	O
inhibition	O
leads	O
to	O
an	O
arrest	O
of	O
the	O
parasite	O
's	I:C0030498
growth	O
and	O
cures	O
malaria	B:C0024530
in	O
a	O
mouse	O
model	I:C2986594
.	O

The	O
enzymes	O
responsible	O
for	O
the	O
synthesis	O
of	O
phosphatidylcholine	O
and	O
phosphatidylethanolamine	O
are	O
attractive	O
drug	O
targets	O
to	O
treat	O
malaria	O
as	O
their	O
selective	O
inhibition	O
leads	O
to	O
an	O
arrest	O
of	O
the	O
parasite	O
's	I:C0030498
growth	O
and	O
cures	O
malaria	O
in	O
a	O
mouse	B:C2986594
model	I:C2986594
.	O

We	O
present	O
here	O
a	O
detailed	O
study	B:C2603343
that	O
reveals	O
a	O
mode	O
of	O
action	O
for	O
two	O
P.	O
falciparum	I:C0032150
choline	O
kinase	I:C0008415
inhibitors	O
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

We	O
present	O
here	O
a	O
detailed	O
study	O
that	O
reveals	O
a	O
mode	O
of	O
action	O
for	O
two	O
P.	B:C0032150
falciparum	I:C0032150
choline	O
kinase	I:C0008415
inhibitors	O
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

We	O
present	O
here	O
a	O
detailed	O
study	O
that	O
reveals	O
a	O
mode	O
of	O
action	O
for	O
two	O
P.	O
falciparum	I:C0032150
choline	B:C0008415
kinase	I:C0008415
inhibitors	O
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

We	O
present	O
here	O
a	O
detailed	O
study	O
that	O
reveals	O
a	O
mode	O
of	O
action	O
for	O
two	O
P.	O
falciparum	I:C0032150
choline	O
kinase	I:C0008415
inhibitors	B:C0243077
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

We	O
present	O
here	O
a	O
detailed	O
study	O
that	O
reveals	O
a	O
mode	O
of	O
action	O
for	O
two	O
P.	O
falciparum	I:C0032150
choline	O
kinase	I:C0008415
inhibitors	O
both	O
in	O
vitro	O
and	O
in	B:C1515655
vivo	I:C1515655
.	O

The	O
compounds	O
present	O
distinct	O
binding	B:C1167622
modes	O
to	O
the	O
choline	O
/	O
ethanolamine	O
-	O
binding	O
site	I:C0005456
of	O
P.	O
falciparum	I:C0032150
choline	O
kinase	I:C0008415
,	O
reflecting	O
different	O
types	O
of	O
inhibition	O
.	O

The	O
compounds	O
present	O
distinct	O
binding	O
modes	O
to	O
the	O
choline	B:C0008405
/	O
ethanolamine	O
-	O
binding	O
site	I:C0005456
of	O
P.	O
falciparum	I:C0032150
choline	O
kinase	I:C0008415
,	O
reflecting	O
different	O
types	O
of	O
inhibition	O
.	O

The	O
compounds	O
present	O
distinct	O
binding	O
modes	O
to	O
the	O
choline	O
/	O
ethanolamine	B:C0059696
-	O
binding	O
site	I:C0005456
of	O
P.	O
falciparum	I:C0032150
choline	O
kinase	I:C0008415
,	O
reflecting	O
different	O
types	O
of	O
inhibition	O
.	O

The	O
compounds	O
present	O
distinct	O
binding	O
modes	O
to	O
the	O
choline	O
/	O
ethanolamine	O
-	O
binding	B:C0005456
site	I:C0005456
of	O
P.	O
falciparum	I:C0032150
choline	O
kinase	I:C0008415
,	O
reflecting	O
different	O
types	O
of	O
inhibition	O
.	O

The	O
compounds	O
present	O
distinct	O
binding	O
modes	O
to	O
the	O
choline	O
/	O
ethanolamine	O
-	O
binding	O
site	I:C0005456
of	O
P.	B:C0032150
falciparum	I:C0032150
choline	O
kinase	I:C0008415
,	O
reflecting	O
different	O
types	O
of	O
inhibition	O
.	O

The	O
compounds	O
present	O
distinct	O
binding	O
modes	O
to	O
the	O
choline	O
/	O
ethanolamine	O
-	O
binding	O
site	I:C0005456
of	O
P.	O
falciparum	I:C0032150
choline	B:C0008415
kinase	I:C0008415
,	O
reflecting	O
different	O
types	O
of	O
inhibition	O
.	O

Strikingly	O
,	O
these	O
compounds	O
primarily	O
inhibit	O
the	O
ethanolamine	B:C1150468
kinase	I:C1150468
activity	I:C1150468
of	O
the	O
P.	O
falciparum	I:C0032150
choline	O
kinase	I:C0008415
,	O
leading	O
to	O
a	O
severe	O
decrease	O
in	O
the	O
phosphatidylethanolamine	O
levels	O
within	O
P.	O
falciparum	I:C0032150
,	O
which	O
explains	O
the	O
resulting	O
growth	O
phenotype	O
and	O
the	O
parasites	O
death	O
.	O

Strikingly	O
,	O
these	O
compounds	O
primarily	O
inhibit	O
the	O
ethanolamine	O
kinase	I:C1150468
activity	I:C1150468
of	O
the	O
P.	B:C0032150
falciparum	I:C0032150
choline	O
kinase	I:C0008415
,	O
leading	O
to	O
a	O
severe	O
decrease	O
in	O
the	O
phosphatidylethanolamine	O
levels	O
within	O
P.	O
falciparum	I:C0032150
,	O
which	O
explains	O
the	O
resulting	O
growth	O
phenotype	O
and	O
the	O
parasites	O
death	O
.	O

Strikingly	O
,	O
these	O
compounds	O
primarily	O
inhibit	O
the	O
ethanolamine	O
kinase	I:C1150468
activity	I:C1150468
of	O
the	O
P.	O
falciparum	I:C0032150
choline	B:C0008415
kinase	I:C0008415
,	O
leading	O
to	O
a	O
severe	O
decrease	O
in	O
the	O
phosphatidylethanolamine	O
levels	O
within	O
P.	O
falciparum	I:C0032150
,	O
which	O
explains	O
the	O
resulting	O
growth	O
phenotype	O
and	O
the	O
parasites	O
death	O
.	O

Strikingly	O
,	O
these	O
compounds	O
primarily	O
inhibit	O
the	O
ethanolamine	O
kinase	I:C1150468
activity	I:C1150468
of	O
the	O
P.	O
falciparum	I:C0032150
choline	O
kinase	I:C0008415
,	O
leading	O
to	O
a	O
severe	O
decrease	O
in	O
the	O
phosphatidylethanolamine	B:C1450468
levels	O
within	O
P.	O
falciparum	I:C0032150
,	O
which	O
explains	O
the	O
resulting	O
growth	O
phenotype	O
and	O
the	O
parasites	O
death	O
.	O

Strikingly	O
,	O
these	O
compounds	O
primarily	O
inhibit	O
the	O
ethanolamine	O
kinase	I:C1150468
activity	I:C1150468
of	O
the	O
P.	O
falciparum	I:C0032150
choline	O
kinase	I:C0008415
,	O
leading	O
to	O
a	O
severe	O
decrease	O
in	O
the	O
phosphatidylethanolamine	O
levels	O
within	O
P.	B:C0032150
falciparum	I:C0032150
,	O
which	O
explains	O
the	O
resulting	O
growth	O
phenotype	O
and	O
the	O
parasites	O
death	O
.	O

Strikingly	O
,	O
these	O
compounds	O
primarily	O
inhibit	O
the	O
ethanolamine	O
kinase	I:C1150468
activity	I:C1150468
of	O
the	O
P.	O
falciparum	I:C0032150
choline	O
kinase	I:C0008415
,	O
leading	O
to	O
a	O
severe	O
decrease	O
in	O
the	O
phosphatidylethanolamine	O
levels	O
within	O
P.	O
falciparum	I:C0032150
,	O
which	O
explains	O
the	O
resulting	O
growth	O
phenotype	O
and	O
the	O
parasites	B:C0030498
death	O
.	O

Strikingly	O
,	O
these	O
compounds	O
primarily	O
inhibit	O
the	O
ethanolamine	O
kinase	I:C1150468
activity	I:C1150468
of	O
the	O
P.	O
falciparum	I:C0032150
choline	O
kinase	I:C0008415
,	O
leading	O
to	O
a	O
severe	O
decrease	O
in	O
the	O
phosphatidylethanolamine	O
levels	O
within	O
P.	O
falciparum	I:C0032150
,	O
which	O
explains	O
the	O
resulting	O
growth	O
phenotype	O
and	O
the	O
parasites	O
death	B:C0011065
.	O

These	O
studies	O
provide	O
an	O
understanding	O
of	O
the	O
mode	O
of	O
action	O
,	O
and	O
act	O
as	O
a	O
springboard	O
for	O
continued	O
antimalarial	B:C0243107
development	I:C0243107
efforts	O
selectively	O
targeting	O
P.	O
falciparum	I:C0032150
choline	O
kinase	I:C0008415
.	O

These	O
studies	O
provide	O
an	O
understanding	O
of	O
the	O
mode	O
of	O
action	O
,	O
and	O
act	O
as	O
a	O
springboard	O
for	O
continued	O
antimalarial	O
development	I:C0243107
efforts	O
selectively	O
targeting	O
P.	B:C0032150
falciparum	I:C0032150
choline	O
kinase	I:C0008415
.	O

These	O
studies	O
provide	O
an	O
understanding	O
of	O
the	O
mode	O
of	O
action	O
,	O
and	O
act	O
as	O
a	O
springboard	O
for	O
continued	O
antimalarial	O
development	I:C0243107
efforts	O
selectively	O
targeting	O
P.	O
falciparum	I:C0032150
choline	B:C0008415
kinase	I:C0008415
.	O

